REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $731,665 | +92.4% | 7,176 | +71.6% | 0.00% | – |
| Q1 2023 | $380,318 | +10.7% | 4,183 | -53.7% | 0.00% | – |
| Q4 2022 | $343,544 | +30.1% | 9,043 | +244.4% | 0.00% | – |
| Q3 2021 | $264,000 | -29.2% | 2,626 | -0.3% | 0.00% | – |
| Q2 2021 | $373,000 | +37.1% | 2,633 | -3.6% | 0.00% | – |
| Q1 2021 | $272,000 | -6.2% | 2,731 | +16.4% | 0.00% | – |
| Q4 2020 | $290,000 | +7.4% | 2,347 | +35.5% | 0.00% | – |
| Q2 2020 | $270,000 | -21.7% | 1,732 | +2.5% | 0.00% | – |
| Q4 2019 | $345,000 | – | 1,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |